Nawal Ouzren Chief Executive Officer SENSORION
Nawal Ouzren joined Sensorion as CEO in April 2017. She has around 20 years of experience in operational and strategic management within the pharmaceutical and biotech industry. Mrs. Ouzren started out at GE before moving to Baxter, where she was Strategy and Operational Excellence Manager, Quality Operations Director and Senior Director Strategy before becoming Vice President of the BioSimilars business unit. In 2014, she became Vice President of the Global Hemophilia Franchise at Baxalta, which had been incorporated within the Shire group. In 2016, she headed up the Global Genetic Diseases Franchise at Shire, where she supervised all marketing, business and strategy aspects of this global division’s product portfolio. She recently was an independent board member of Inventiva from 2019 to 2021. She is a board member of Sensorion and serves as a non-executive director of Arena Pharmaceuticals.